NCT01728623View on ClinicalTrials.gov

A Study of E7080 in Subjects With Advanced Thyroid Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

September 3, 2012

Primary Completion Date

July 9, 2015

Study Completion Date

October 1, 2015

Conditions
Thyroid Cancer
Interventions
DRUG

E7080 capsule

E7080 is administered as continuous once daily dosing in an uncontrolled manner

Trial Locations (3)

Unknown

Kashiwa

Kobe

Koto-ward

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT01728623 - A Study of E7080 in Subjects With Advanced Thyroid Cancer | Biotech Hunter | Biotech Hunter